New Pharma Tech Survey: Hear from 100+ Investors and Entrepreneurs LEARN MORE

McKesson Ventures
  • Portfolio
  • News & Insights
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada

by McKesson Ventures | Apr 28, 2025 | Press Releases

On Monday, April 28th, clinical real-world data (RWD) company Atropos Health announced that it would be collaborating with community oncology real-world data (RWD) provider Ontada to enhance oncology data use cases for clinicians, researchers, and healthcare leaders —...

ChatRWD™ Beta from Atropos Health Exceeds Big Tech LLMs on Physician Trust and Ability to Answer Questions Completely with High-Quality Evidence in New Study

by McKesson Ventures | Jul 2, 2024 | Press Releases

On July 2, real-world data healthcare technology company Atropos Health announced in a press release the publication of its new research paper, “Answering Real-World Clinical Questions Using Large Language Model Based Systems.” The paper offers a detailed look into...

Atropos Health Raises $33M To Scale The Automation Of High-Quality, Personalized Real-World Evidence Leveraging Generative AI

by McKesson Ventures | May 23, 2024 | Portfolio News, Press Releases

On Thursday, May 23, real-world data healthcare technology company Atropos Health announced that it had secured a $33 million Series B financing round, in light of the recent adoption of the company’s GENEVA OS™ platform, which is now being used by a variety of...
Page 2 of 2«12

Recent Posts

  • Komodo Health Wins 2026 Fierce AI Innovation Award for Commercial Strategy & Launch from Fierce Pharma
  • Silver and LYNX Launch Production AI Claims Automation to Help TPAs Modernize Claims Processing
  • HarmonyCares Ranks Among Medicare’s Top ACO REACH Performers for 2024
  • UNC Health Scales Medication Access By Over 45% Without Adding Headcount Using Latent Health’s Pharmacy Intelligence Platform
  • Reimagine Care Expands AI-Enabled Virtual Oncology Model with Moffitt Cancer Center Following Strong Patient and Clinical Outcomes
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings